These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9147012)

  • 1. Reductive activation of nitroheterocyclic compounds.
    Tocher JH
    Gen Pharmacol; 1997 Apr; 28(4):485-7. PubMed ID: 9147012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of liver enzymes on the mutagenicity of nitroheterocyclic compounds: activation of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)- 1,2-benzisoxazole and deactivation of nitrofurans and nitroimidazoles in the Ames test.
    Skeggs HR; Berglund RM; VandenHeuvel WJ; Mrozik H; Wislocki PG; Wolf FJ
    Mutat Res; 1984 Apr; 136(1):1-8. PubMed ID: 6371510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to the nitroheterocyclic drugs.
    Townson SM; Boreham PF; Upcroft P; Upcroft JA
    Acta Trop; 1994 Mar; 56(2-3):173-94. PubMed ID: 8203303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings.
    Grunberg E; Titsworth EH
    Annu Rev Microbiol; 1973; 27():317-46. PubMed ID: 4584690
    [No Abstract]   [Full Text] [Related]  

  • 5. The versatility of nitro compounds.
    Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1976 Mar; 2(1):5-8. PubMed ID: 931834
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitro reduction as an electronic switch for bioreductive drug activation.
    Siim BG; Denny WA; Wilson WR
    Oncol Res; 1997; 9(6-7):357-69. PubMed ID: 9406242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Activity of 5-membered Nitroheteroaromatic Compounds beyond Nitrofurans and Nitroimidazoles: Recent Progress.
    Kalinin S; Vedekhina T; Paramonova P; Krasavin M
    Curr Med Chem; 2021; 28(29):5926-5982. PubMed ID: 33593249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroimidazoles as anti-tumor agents.
    Liu K; Zhu HL
    Anticancer Agents Med Chem; 2011 Sep; 11(7):687-91. PubMed ID: 21521156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies of four types of nitroheterocyclic radicals by pulse radiolysis. Correlation of pharmacological properties to decay rates.
    Guissani A; Henry Y; Lougmani N; Hickel B
    Free Radic Biol Med; 1990; 8(2):173-89. PubMed ID: 2332194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of clinically utilized 5-nitroimidazoles on microorganisms.
    Müller M
    Scand J Infect Dis Suppl; 1981; 26():31-41. PubMed ID: 6941454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive activation of nitroimidazoles in anaerobic microorganisms.
    Müller M
    Biochem Pharmacol; 1986 Jan; 35(1):37-41. PubMed ID: 3940525
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular biology aspects of the antimicrobial effect of synthetic chemotherapeutic agents].
    Popov N
    Z Arztl Fortbild (Jena); 1982 Aug; 76(15):662-6. PubMed ID: 7150403
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitrosoimidazoles: highly bactericidal analogues of 5-nitroimidazole drugs.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    J Med Chem; 1988 Feb; 31(2):323-9. PubMed ID: 3339605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.
    Watts ME; Jacobs RS
    Br J Cancer Suppl; 1978 Jun; 3():80-3. PubMed ID: 277262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infections.
    Goldman P
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():23-33. PubMed ID: 6749793
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of SQ 18 506 with other nitroheterocyclic compounds on experimental Chagas' disease.
    Gutteridge WE; Gaborak M; Cover B
    Ann Trop Med Parasitol; 1978 Aug; 72(4):339-47. PubMed ID: 80977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing bactericidal activity with combinations of bioreduced drugs.
    Goldman RC
    Future Med Chem; 2010 Aug; 2(8):1253-71. PubMed ID: 21426017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial transformation of nitroaromatic compounds under anaerobic conditions.
    Gorontzy T; Küver J; Blotevogel KH
    J Gen Microbiol; 1993 Jun; 139 Pt 6():1331-6. PubMed ID: 8360625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The 5-nitroimidazoles].
    Gerson C
    Soins; 1993 Nov; (578):59-60. PubMed ID: 8140475
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitroaromatic Antibiotics as Nitrogen Oxide Sources.
    Rice AM; Long Y; King SB
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33673069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.